Ads
related to: alpha-glucosidase inhibitor drugs uses and benefits weight loss side effects
Search results
Results from the WOW.Com Content Network
Since alpha-glucosidase inhibitors prevent the degradation of complex carbohydrates into glucose, the carbohydrates will remain in the intestine. In the colon, bacteria will digest the complex carbohydrates, thereby causing gastrointestinal side effects such as flatulence and diarrhea. Since these effects are dose-related, it is generally ...
Miglitol is an oral alpha-glucosidase inhibitor used in the treatment of type 2 diabetes.It works by reversibly inhibiting alpha-glucosidase enzymes in the small intestine, which delays the digestion of complex carbohydrates and subsequently reduces postprandial glucose levels. [1]
This leads the pancreas to produce more insulin, which helps lower blood sugar levels and promote weight loss. GLP-1 drugs for weight loss and type 2 diabetes include dulaglutide, liraglutide, and ...
GLP-1 analogs resulted in weight loss and had more gastrointestinal side-effects, while in general dipeptidyl peptidase-4 (DPP-4) inhibitors were weight-neutral and are associated with increased risk for infection and headache. Both classes appear to present an alternative to other antidiabetic drugs.
Canvassing all of the health effects of a new drug category like GLP-1s could be a novel way for agencies like the FDA to get an early understanding of a new medication’s potential benefits and ...
Here's the deal: The weight-loss drug space is a little contentious at the moment, but doctors are adamant that these medications can help people with obesity lose weight, and improve health ...
Ads
related to: alpha-glucosidase inhibitor drugs uses and benefits weight loss side effects